263P Diagnostic accuracy of artificial intelligence for early melanoma detection: A systematic review and meta analysis of clinical trials

Early melanoma detection is essential for patient survival, yet diagnostic accuracy varies across settings. Artificial intelligence (AI) systems, including convolutional neural networks (CNNs), are increasingly evaluated in prospective trials as adjuncts or alternatives to clinician assessment. This systematic review assessed trial evidence for AI in suspected melanoma, distinguishing between AI-alone (AI versus human) and AI-assisted (AI plus human versus human) approaches.